Icon Group has almost 30 years’ experience in cancer research and now operates the largest private cancer clinical trials program in Australia. As part of Icon Group, Icon Cancer Centre Hong Kong is committed to providing access to research and clinical trials to patients across ASEAN.

We believe patients across our centres deserve the opportunity to access clinical trials.

To find out more about the research that Icon is participating in, our team and achievements during 2021, please read the 2021 Icon Research Annual Report.

At Icon, our dedicated research program enables our patients to access new and emerging advances in cancer treatment, providing new opportunities to patients and their families.

Icon Group run trials across various tumour types and haematological conditions, including chemotherapy, immunotherapy and radiation therapy trials. Icon also offers trials that are not directly connected to a treatment technique. The aim is always to focus on wellbeing and improving quality of life for our patients.

By providing access to a wide range of clinical trials across a multitude of cancer types, Icon helps to contribute to breakthroughs and advancements in cancer treatments for the benefit of current and future patients.